Industry & Business

Dublin startup scores €85 million funding for new approach to cancer therapy

 Breaking News
  • Largest Ever European Investment Bank Support in Ireland The European Investment Bank is to provide a loan of €490 million to support construction of the new children’s hospital in Dublin. This represents the largest ever financial engagement by the European Union’s long-term lending institution in Ireland and the EIB’s first backing for a hospital in the country. The new children’s hospital project includes two [...]...
  • Strabane Manufacturer to Invest Over £7 Million in Ambitious Expansion Strabane-based Fabplus is planning to more than double its workforce and turnover with support from Invest Northern Ireland. The investment is part of a three year expansion plan to increase its market share in the Republic of Ireland and Great Britain, and gain a foothold in mainland Europe and Scandinavia. Recruitment is underway to employ 83 additional staff at [...]...
  • PM Group Appoints a New Non-Executive Director Michael McNicholas has been appointed as a Non-Executive Director of Project Management Holdings (PM Group), the Irish headquartered international project delivery specialists. Michael McNicholas. Michael has over 35 years’ experience in senior leadership positions in the public and private sectors. He is the former CEO of Ervia, NTR plc and Managing Director of ESB International.  During his [...]...
  • Center Parcs Signs Contract With John Sisk & Son As construction activity on the much anticipated €233 million Center Parcs Longford Forest resort in County Longford ramps up, the company has announced it has formally awarded two major construction contracts to Dublin-based construction firm John Sisk & Son. The contracts for the construction of the 470 lodges and 30 apartments as well as the state-of-the-art centre [...]...
  • Medi-Shower Invests in Innovation to Drive Export Growth Multi-award-winning manufacturer Medi-Shower has created ‘smart showerhead’ technology which can reduce the risk of Legionnaires disease. The cutting edge product, developed with R&D support from Invest Northern Ireland is designed to meet the high requirements for hygiene within the healthcare sector. It reduces the risk of waterborne infection from bacteria that can build up due to poor design [...]...

Dublin startup scores €85 million funding for new approach to cancer therapy

Dublin startup scores €85 million funding for new approach to cancer therapy
October 04
10:07 2016

Carrick Therapeutics, a Dublin-based startup specialising in a unique approach to cancer therapies, has launched having secured $95 (€85) million in funding.

Heavyweight investors have lined up to support the Irish company, with US firm ARCH Venture Partners, leading UK firm Woodford Investment Management and GV (Google Ventures) among those who have provided the capital. Lightstone Ventures, which is supported by Enterprise Ireland and the Irish Strategic Investment Fund, has also support Carrick.

The company will aim to build an innovative portfolio of first-in-class treatments that are advanced through understanding the mechanisms that cause cancer and resistance and tailored to an individual patient’s tumour.

Personalised cancer medicine, which is targeted at that specific patient’s cancer, is seen as a crucial next step in the fight against the disease. Cancer is so difficult to treat because of its unpredictability, but new scientific advances are developing more and more of an understanding about it affects each person.

Carrick Therapeutics has set out a clear vision to target the molecular pathways that drive the most aggressive and resistant forms of cancer in order to have a major impact on the lives of patients. With such large funding, the company will look to develop a portfolio of first-in-class treatments, rather than a single compound or biological mechanism.

Their CEO, Dr Elaine Sullivan, has previously worked as Vice President for Research and Development for pharma giants Eli Lilly and AstraZeneca.

She comments: “Our aim is to build Europe’s leading oncology company. There is a significant unmet need in cancer treatment, and targeting aggressive and resistant disease is an area where we can make a real difference to patients’ lives.”

Sullivan has indicated that Ireland was an ideal choice for their base of operations due to the opportunities for collaboration with clinicians and scientists, and because its skilled workforce makes it a great place for recruitment.

About Author

admin

admin

Related Articles






New Subscriber





Subscribe Here



Advertisements
































National Manufacturing Conference & Exhibition 2016

NIBRT Springboard Success Stories



Upcoming Events

  • No upcoming events
AEC v1.0.4